Cardiovascular actions of Wy 21901, a new hypotensive and anti-arrhythmic agent.
作者信息
Alps B J, Johnson E S, Wilson A B
出版信息
Br J Pharmacol. 1970 Sep;40(1):151P-152P.
Abstract
摘要
相似文献
1
Cardiovascular actions of Wy 21901, a new hypotensive and anti-arrhythmic agent.新型降压及抗心律失常药物Wy 21901的心血管作用
Br J Pharmacol. 1970 Sep;40(1):151P-152P.
2
[Cardiovascular effects and antiarrhythmic action of a new beta adrenergic blocker, LB-46].
Masui. 1970 May;19(5):515-22.
3
Autonomic blocking properties of Wy 21901.Wy 21901的自主神经阻断特性。
Br J Pharmacol. 1970 Sep;40(1):153P.
4
A comparison of the cardiovascular actions of indoramin, propranolol, lignocaine, and quinidine.吲哚拉明、普萘洛尔、利多卡因和奎尼丁对心血管作用的比较。
Cardiovasc Res. 1972 May;6(3):226-34. doi: 10.1093/cvr/6.3.226.
5
Cardiovascular pharmacology of two new beta-adrenergic receptor antagonists.两种新型β-肾上腺素能受体拮抗剂的心血管药理学
J Pharmacol Exp Ther. 1965 Aug;149(2):174-82.
6
The effects of lidocaine, hexamethonium and alpha and beta adrenergic blocking agents on the pulmonary veins in intact dogs.
J Pharmacol Exp Ther. 1970 Sep;174(3):487-99.
7
Influence of adrenergic beta-receptor blockade on the acute cardiovascular effects of hydralazine.肾上腺素能β受体阻滞剂对肼屈嗪急性心血管效应的影响。
Br J Pharmacol Chemother. 1967 May;30(1):123-33. doi: 10.1111/j.1476-5381.1967.tb02118.x.
8
A comparative study of the beta adrenergic blocking activities of propranolol and inpea.
J Pharmacol Exp Ther. 1968 May;161(1):111-21.
9
引用本文的文献
1
Myocardial effects of indoramin hydrochloride, a new hypotensive agent.新型降压药盐酸吲哚拉明的心肌效应
Br J Pharmacol. 1971 Aug;42(4):664P-665P.
2
Proceedings: Haemodynamic effects of indoramin: a non-invasive technique for the cardiovascular evaluation of drugs.会议论文：吲哚拉明的血流动力学效应：一种用于药物心血管评估的非侵入性技术。
Br J Pharmacol. 1972 Feb;44(2):387P-388P.
3
Proceedings: Initial clinical experience with indoramin, a new antihypertensive agent.论文集：新型抗高血压药物吲哚拉明的初步临床经验。
Br J Pharmacol. 1972 Feb;44(2):379P-380P.
4
Double blind controlled trial of indoramin in the treatment of essential hypertension.吲哚拉明治疗原发性高血压的双盲对照试验
Br J Pharmacol. 1972 Nov;46(3):542P-543P.
5
Quantitative analysis on isolated organs of the autonomic blocking properties of indoramin hydrochloride (Wy 21901).盐酸吲哚拉明（Wy 21901）自主神经阻滞特性的离体器官定量分析。
Br J Pharmacol. 1972 Jan;44(1):52-62. doi: 10.1111/j.1476-5381.1972.tb07237.x.
6
Autonomic blocking properties of Wy 21901.Wy 21901的自主神经阻断特性。
Br J Pharmacol. 1970 Sep;40(1):153P.
7
Clinical evaluation of indoramin, a new antihypertensive agent.
Eur J Clin Pharmacol. 1973 Dec;6(4):211-6. doi: 10.1007/BF00644733.
8
Pharmacokinetics of indoramin in man.吲哚拉明在人体中的药代动力学。
Br J Clin Pharmacol. 1976 Jun;3(3):489-95. doi: 10.1111/j.1365-2125.1976.tb00626.x.
本文引用的文献
1
Treatment of hypertension with propranolol.用普萘洛尔治疗高血压。
Br Med J. 1969 Jan 4;1(5635):7-16. doi: 10.1136/bmj.1.5635.7.
2
Controlled trial of propranolol in hypertension.普萘洛尔治疗高血压的对照试验。
Br Med J. 1970 Feb 21;1(5694):471-4. doi: 10.1136/bmj.1.5694.471.
3
Autonomic blocking properties of Wy 21901.Wy 21901的自主神经阻断特性。
Br J Pharmacol. 1970 Sep;40(1):153P.
Zotero 插件